Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-03, Stock:JNJ, The news for the past five days is as follows:
2018-06-26: NEWS1: Gauging Analysts’ Ratings for TransEnterix and Peers in June.NEWS2: Technology Sector Update for 06/26/2018: FTV,CRM,AVNW,SLP.NEWS3: Technology Sector Update for 06/26/2018: FTV,CRM,AVNW,SLP.NEWS4: AbbVie's (ABBV) Imbruvica sNDA Gets Priority Review From FDA.NEWS5: AbbVie's (ABBV) Imbruvica sNDA Gets Priority Review From FDA.NEWS6: Dow Analyst Moves: JNJ.NEWS7: Dow Analyst Moves: JNJ.NEWS8: If You're in Your 70s, Consider Buying These 3 Stocks.NEWS9: If You're in Your 70s, Consider Buying These 3 Stocks.NEWS10: Insulin Pump Maker’s 900% Stock Surge Has More Room to Run.NEWS11: This “Preferred” Fund Crushes ETFs and Pays 7.3% in Cash.NEWS12: This “Preferred” Fund Crushes ETFs and Pays 7.3% in Cash.NEWS13: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS14: Champions of Science: The Art of Ending Stigma Project Launches to Combat Stigma About Mental Illnesses Through Education and Artistic Creation.
2018-06-27: NEWS1: A Look at Eli Lilly’s Valuations on June 25.NEWS2: AbbVie (ABBV), Calico Extend R&D Deal, to Invest $500M Each.NEWS3: AbbVie (ABBV), Calico Extend R&D Deal, to Invest $500M Each.NEWS4: ITOT, JPM, XOM, JNJ: ETF Inflow Alert.NEWS5: ITOT, JPM, XOM, JNJ: ETF Inflow Alert.NEWS6: Dow Movers: MCD, GE.NEWS7: Dow Movers: MCD, GE.NEWS8: AbbVie (ABBV), Calico Extend R&D Deal, to Invest $500M Each.NEWS9: See what the IHS Markit Score report has to say about Johnson & Johnson..
2018-06-28: NEWS1: Top Analyst Reports for Johnson & Johnson, Biogen & General Motors.NEWS2: Top Analyst Reports for Johnson & Johnson, Biogen & General Motors.NEWS3: Top Analyst Reports for Johnson & Johnson, Biogen & General Motors.NEWS4: MDT’s Diabetes Business Could Significantly Boost Its Revenue.NEWS5: Amgen Announces Top-Line Data From Remicade Biosimilar Study.NEWS6: Amgen Announces Top-Line Data From Remicade Biosimilar Study.NEWS7: Amgen Announces Top-Line Data From Remicade Biosimilar Study.NEWS8: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS9: STADA Buys EMEA Rights To J&J's Medicated Anti-dandruff Shampoo Nizoral.NEWS10: STADA Buys EMEA Rights To J&J's Medicated Anti-dandruff Shampoo Nizoral.
2018-06-29: NEWS1: Missouri appeals court tosses $55 million J&J talc-powder verdict.NEWS2: Missouri appeals court tosses $55 mln J&J talc-powder verdict.NEWS3: The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, General Motors, Valero and Ameriprise.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, General Motors, Valero and Ameriprise.NEWS5: Missouri appeals court tosses $55 mln J&J talc-powder verdict.NEWS6: The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, General Motors, Valero and Ameriprise.
2018-07-02: NEWS1: Final Trade: JNJ, JD & CAR.NEWS2: 7 ETFs Where Dividends and Low Volatility Meet.NEWS3: 4 Drug and Biotech Stocks Awaiting FDA Decisions in July.NEWS4: 4 Drug and Biotech Stocks Awaiting FDA Decisions in July.NEWS5: See what the IHS Markit Score report has to say about Johnson & Johnson..

Answer: Rise